Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

Siglecs and their roles in the immune system

Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754

The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354

Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057

Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor

Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855

From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins

Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691

A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission

Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 580

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality

Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 413

Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells

Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 399

Biological roles of glycans

Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635

IgG Subclasses and Allotypes: From Structure to Effector Functions

Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Schwab, I., & Nimmerjahn, F. (2013) · Nature reviews. Immunology · doi:10.1038/nri3401 · Cited by 818

Glycosylation as a strategy to improve antibody-based therapeutics

Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829

Mammalian glycosylation in immunity

Marth, J. D., & Grewal, P. K. (2008) · Nature reviews. Immunology · doi:10.1038/nri2417 · Cited by 719

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V. (2011) · Nature · doi:10.1038/nature10134 · Cited by 642

Identification of a receptor required for the anti-inflammatory activity of IVIG

Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 557

High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

Pučić‐Baković, M., Knežević, A., Vidič, J., Adamczyk, B., Novokmet, M., Polašek, O., Gornik, O., Goreta, S. Š., Wormald, M. R., Redžić, I., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010090 · Cited by 531

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

Raju, T. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.007 · Cited by 544

Type I and type II Fc receptors regulate innate and adaptive immunity

Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B. M., & Ravetch, J. V. (2014) · Nature Immunology · doi:10.1038/ni.2939 · Cited by 517

Glycosylation: mechanisms, biological functions and clinical implications

He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 585

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 497

Human plasma protein N-glycosylation

Clerc, F., Reiding, K. R., Jansen, B. C., Lageveen‐Kammeijer, G. S. M., Bondt, A., & Wuhrer, M. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9626-2 · Cited by 459

Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins

Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428

Emerging principles for the therapeutic exploitation of glycosylation

Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447

Immunoglobulin G glycosylation in aging and diseases

Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 422

Fc glycans of therapeutic antibodies as critical quality attributes

Reusch, D., & Tejada, M. L. (2015) · Glycobiology · doi:10.1093/glycob/cwv065 · Cited by 421

The Challenge and Promise of Glycomics

Cummings, R. D., & Pierce, J. M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.010 · Cited by 400

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., et al. (2017) · Science · doi:10.1126/science.aai8128 · Cited by 371

Modulating IgG effector function by Fc glycan engineering

Li, T., DiLillo, D. J., Bournazos, S., Giddens, J. P., Ravetch, J. V., & Wang, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702173114 · Cited by 323

The Immunoregulatory Roles of Antibody Glycosylation

Jennewein, M. F., & Alter, G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.004 · Cited by 336

Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease

Pfeifle, R., Rothe, T., Ipseiz, N., Scherer, H. U., Culemann, S., Steffen, U., Ackermann, J. A., Seefried, M., Kleyer, A., Uderhardt, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3579 · Cited by 320

Electrochemistry of Nonconjugated Proteins and Glycoproteins. Toward Sensors for Biomedicine and Glycomics

Paleček, E., Tkáč, J., Bartošík, M., Bertók, T., Ostatná, V., & Palecek, J. J. (2015) · Chemical Reviews · doi:10.1021/cr500279h · Cited by 316

A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

Anthony, R. M., & Ravetch, J. V. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9405-6 · Cited by 317

Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions

Huang, W., Giddens, J. P., Fan, S., Toonstra, C., & Wang, L. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3051266 · Cited by 308

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

Lünemann, J. D., Nimmerjahn, F., & Dalakas, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.253 · Cited by 313

Advances in the assessment and control of the effector functions of therapeutic antibodies

Jiang, X., Song, A., Bergelson, S., Arroll, T. W., Parekh, B. S., May, K. M. L., Chung, S., Strouse, R., Mire‐Sluis, A. R., & Schenerman, M. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3365 · Cited by 306

Antibody‐mediated modulation of immune responses

Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 293

Enzymes in the Synthesis of Glycoconjugates

Schmaltz, R. M., Hanson, S. R., & Wong, C. (2011) · Chemical Reviews · doi:10.1021/cr200113w · Cited by 291

IgG glycosylation analysis

Huhn, C., Selman, M. H. J., Ruhaak, L. R., Deelder, A. M., & Wuhrer, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800715 · Cited by 301

Management of Myocarditis-Related Cardiomyopathy in Adults

Tschöpe, C., Cooper, L. T., Torre‐Amione, G., & Linthout, S. V. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 283

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

Quast, I., Keller, C. W., Maurer, M., Giddens, J. P., Tackenberg, B., Wang, L., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 270

Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

Vučković, F., Krištić, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pučić‐Baković, M., Štambuk, J., Trbojević‐Akmačić, I., Barrios, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39273 · Cited by 270

IVIG-mediated effector functions in autoimmune and inflammatory diseases

Galeotti, C., Kaveri, S. V., & Bayry, J. (2017) · International Immunology · doi:10.1093/intimm/dxx039 · Cited by 272

IgA subclasses have different effector functions associated with distinct glycosylation profiles

Steffen, U., Koeleman, C. A. M., Sokolova, M. V., Bang, H., Kleyer, A., Rech, J., Unterweger, H., Schicht, M., Garreis, F., Hahn, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13992-8 · Cited by 257

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss

Steffen, U., Lang, S. C., Pfeifle, R., Rombouts, Y., Frühbeißer, S., Amara, K., Bang, H., Lux, A., Koeleman, C. A. M., Baum, W., et al. (2015) · Nature Communications · doi:10.1038/ncomms7651 · Cited by 264

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

Ballow, M. C. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 259

Mass Spectrometry and the Emerging Field of Glycomics

Zaia, J. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.016 · Cited by 252

Mass Spectrometry and Glycomics

Zaia, J. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0146 · Cited by 249

Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 243

Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag

Wu, P., Shui, W., Carlson, B. L., Hu, N., Rabuka, D., Lee, J., & Bertozzi, C. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807820106 · Cited by 237

Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine

Hudak, J. E., & Bertozzi, C. R. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.010 · Cited by 232

N-glycomic biomarkers of biological aging and longevity: A link with inflammaging

Dall’Olio, F., Vanhooren, V., Chen, C. C., Slagboom, P. E., Wuhrer, M., & Franceschi, C. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.002 · Cited by 237

In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway

Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jeż, J., Gattinger, P., Kunert, R., Quendler, H., Pabst, M., Leonard, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088401 · Cited by 230

Intravenous immunoglobulins – understanding properties and mechanisms

Durandy, A., Kaveri, S. V., Kuijpers, T. W., Bašta, M., Miescher, S., Ravetch, J. V., & Rieben, R. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04022.x · Cited by 229

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225

Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid

Scherer, H. U., van der Woude, D., Ioan‐Facsinay, A., Bannoudi, H. E., Trouw, L. A., Wang, J., Häupl, T., Burmester, G. R., Deelder, A. M., Huizinga, T. W. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27414 · Cited by 230

Mass spectrometry in the analysis of N-linked and O-linked glycans

North, S. J., Hitchen, P. G., Haslam, S. M., & Dell, A. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.05.005 · Cited by 221

Quality Attributes of Recombinant Therapeutic Proteins: An Assessment of Impact on Safety and Efficacy as Part of a Quality by Design Development Approach

Eon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234

General mechanism for modulating immunoglobulin effector function

Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 227

Chemical assembly of N-glycoproteins: a refined toolbox to address a ubiquitous posttranslational modification

Unverzagt, C., & Kajihara, Y. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35485g · Cited by 218

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

Mimura, Y., Katoh, T., Saldova, R., O’Flaherty, R., Izumi, T., Mimura‐Kimura, Y., Utsunomiya, T., Mizukami, Y., Yamamoto, K., Matsumoto, T., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0433-3 · Cited by 221

Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs

Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 223

Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease

Pagan, J. D., Kitaoka, M., & Anthony, R. M. (2017) · Cell · doi:10.1016/j.cell.2017.11.041 · Cited by 206

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

Wang, T. T., Maamary, J., Tan, G. S., Bournazos, S., Davis, C. W., Krammer, F., Schlesinger, S. J., Palese, P., Ahmed, R., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.06.026 · Cited by 198

A common glycan structure on immunoglobulin G for enhancement of effector functions

Lin, C., Tsai, M.-H., Li, S., Tsai, T.-I., Chu, K., Liu, Y.-C., Lai, M.-Y., Wu, C.-Y., Tseng, Y.-C., Shivatare, S. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513456112 · Cited by 202

Modulation of the cellular immune system by intravenous immunoglobulin

Tha‐In, T., Bayry, J., Metselaar, H. J., Kaveri, S. V., & Kwekkeboom, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.004 · Cited by 199

The history of IgG glycosylation and where we are now

Cobb, B. A. (2019) · Glycobiology · doi:10.1093/glycob/cwz065 · Cited by 200

Functional diversification of IgGs through Fc glycosylation

Wang, T. T., & Ravetch, J. V. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130029 · Cited by 195

Novel roles for the IgG Fc glycan

Anthony, R. M., Wermeling, F., & Ravetch, J. V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06305.x · Cited by 190

NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic

Barb, A. W., & Prestegard, J. H. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.511 · Cited by 190

A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation

Schwarz, F., Huang, W., Li, C., Schulz, B. L., Lizak, C., Palumbo, A., Numao, S., Neri, D., Aebi, M., & Wang, L. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.314 · Cited by 186

Antibody glycosylation in inflammation, disease and vaccination

Alter, G., Ottenhoff, T. H. M., & Joosten, S. A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.003 · Cited by 186

Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms

Wada, R., Matsui, M., & Kawasaki, N. (2019) · mAbs · doi:10.1080/19420862.2018.1551044 · Cited by 186

Immunotherapy in myasthenia gravis in the era of biologics

Dalakas, M. C. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0110-z · Cited by 190

Biological function of sialic acid and sialylation in human health and disease

Zhu, W., Zhou, Y., Guo, L., & Feng, S. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02180-3 · Cited by 183

Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Seeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 185

Aglycosylated immunoglobulin G 1 variants productively engage activating Fc receptors

Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 182

The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor

Subedi, G. P., & Barb, A. W. (2016) · mAbs · doi:10.1080/19420862.2016.1218586 · Cited by 180

Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen

McGaha, T. L., Chen, Y., Ravishankar, B., van Rooijen, N., & Karlsson, M. C. I. (2011) · Blood · doi:10.1182/blood-2010-11-320028 · Cited by 178

Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis

Ohmi, Y., Ise, W., Harazono, A., Takakura, D., Fukuyama, H., Baba, Y., Narazaki, M., Shoda, H., Takahashi, N., Ohkawa, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11205 · Cited by 171

Optimization of Fc-mediated effector functions of monoclonal antibodies

Strohl, W. R. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.011 · Cited by 174

Advances in Enzymatic Glycoside Synthesis

Danby, P. M., & Withers, S. G. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00340 · Cited by 167

Sialylation of immunoglobulin E is a determinant of allergic pathogenicity

Shade, K.-T., Conroy, M. E., Washburn, N., Kitaoka, M., Huynh, D. J., Laprise, E., Patil, S. U., Shreffler, W. G., & Anthony, R. M. (2020) · Nature · doi:10.1038/s41586-020-2311-z · Cited by 167

Chemoenzymatic Synthesis and Fcγ Receptor Binding of Homogeneous Glycoforms of Antibody Fc Domain. Presence of a Bisecting Sugar Moiety Enhances the Affinity of Fc to FcγIIIa Receptor

Zou, G., Ochiai, H., Huang, W., Yang, Q., Li, C., & Wang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208390n · Cited by 171

To B or not to B: B cells and the Th2-type immune response to helminths

Harris, N., & Gause, W. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.005 · Cited by 166

Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health

Plomp, R., Ruhaak, L. R., Uh, H., Reiding, K. R., Selman, M. H. J., Houwing‐Duistermaat, J. J., Slagboom, P. E., Beekman, M., & Wuhrer, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12495-0 · Cited by 167

Chemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions

Wang, L., & Amin, M. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.001 · Cited by 164

Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli

Wang, J., Balog, C. I. A., Stavenhagen, K., Koeleman, C. A. M., Scherer, H. U., Selman, M. H. J., Deelder, A. M., Huizinga, T. W. J., Toes, R. E. M., & Wuhrer, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004655 · Cited by 163

A single glycan on IgE is indispensable for initiation of anaphylaxis

Shade, K.-T., Platzer, B., Washburn, N., Mani, V., Bartsch, Y. C., Conroy, M. E., Pagan, J. D., Bosques, C. J., Mempel, T. R., Fiebiger, E., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142182 · Cited by 154

Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

Chu, S. Y., Voštiar, I., Karki, S., Moore, G. L., Lazar, G. A., Pong, E., Joyce, P. F., Szymkowski, D. E., & Desjarlais, J. R. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.027 · Cited by 153

Changes in IgG and total plasma protein glycomes in acute systemic inflammation

Novokmet, M., Lukić, E., Vučković, F., Đurić, Ž., Keser, T., Rajšl, K., Remondini, D., Castellani, G., Gašparović, H., Gornik, O., et al. (2014) · Scientific Reports · doi:10.1038/srep04347 · Cited by 156

Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells

Massoud, A. H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W. M., Piccirillo, C. A., & Mazer, B. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.029 · Cited by 161

Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins

Ahmed, A. A., Giddens, J. P., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L., & Björkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 156

FcγRs in Health and Disease

Nimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 160

Advances in the understanding of the mechanism of action of IVIg

Hartung, H. (2008) · Journal of Neurology · doi:10.1007/s00415-008-3002-0 · Cited by 152

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies

Gogesch, P., Dudek, S., van Zandbergen, G., Waibler, Z., & Anzaghe, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168947 · Cited by 166

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

Shajahan, A., Archer‐Hartmann, S. A., Supekar, N. T., Gleinich, A. S., Heiß, C., & Azadi, P. (2020) · Glycobiology · doi:10.1093/glycob/cwaa101 · Cited by 148

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

Mahan, A. E., Jennewein, M. F., Suscovich, T. J., Dionne, K., Tedesco, J., Chung, A. W., Streeck, H., Pau, M. G., Schuitemaker, H., Francis, D., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005456 · Cited by 152

N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies

Sha, S., Agarabi, C. D., Brorson, K., Lee, D., & Yoon, S. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.013 · Cited by 156

Fcγ receptor pathways during active and passive immunization

Bournazos, S., & Ravetch, J. V. (2015) · Immunological Reviews · doi:10.1111/imr.12343 · Cited by 151

Intravenous immunoglobulin therapy in rheumatic diseases

Bayry, J., Negi, V. S., & Kaveri, S. V. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.61 · Cited by 145

Emerging methods for the production of homogeneous human glycoproteins

Rich, J. R., & Withers, S. G. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.148 · Cited by 147

Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12

Forthal, D. N., Gach, J. S., Landucci, G., Jeż, J., Strasser, R., Kunert, R., & Steinkellner, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002600 · Cited by 145

Applications of ion mobility mass spectrometry for high throughput, high resolution glycan analysis

Gray, C., Thomas, B., Upton, R., Migas, L. G., Eyers, C. E., Barran, P. E., & Flitsch, S. L. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.02.003 · Cited by 149

The role of sialic acid as a modulator of the anti-inflammatory activity of IgG

Böhm, S., Schwab, I., Lux, A., & Nimmerjahn, F. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0308-x · Cited by 147

Emerging Technologies for Making Glycan-Defined Glycoproteins

Wang, L., & Lomino, J. V. (2011) · ACS Chemical Biology · doi:10.1021/cb200429n · Cited by 138

Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns

del Val, I. J., Kontoravdi, C., & Nagy, J. M. (2010) · Biotechnology Progress · doi:10.1002/btpr.470 · Cited by 150

Fcγ Receptor Heterogeneity in Leukocyte Functional Responses

Rosales, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00280 · Cited by 144

The role and function of Fcγ receptors on myeloid cells

Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138

with a Recombinant IgG Fc Recapitulation of IVIG Anti-Inflammatory Activity

Anthony, R. M. (2008)

Research Highlights

Okoreeh, M. K., & Luo, X. (2026) · Transplantation · doi:10.1097/tp.0000000000005610

The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors

Jones, A., Marino, A. E., Martynyuk, T., Bournazos, S., & Ravetch, J. V. (2025) · Science · doi:10.1126/science.adv2927 · Cited by 11

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225

Novel Fc receptors mediating the anti-inflammatory properties of IgG

Ravetch, J. V. (2010)